Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,928 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Grant · Acquired 55,555 · Balance 91,928 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 12, 2026 20:17 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 55,555 | $0.00 | $0.00 |
DisclosureSEC source: 0002064538-26-000002 · wk-form4_1786565850.xml · nonDerivative · entry 1 Batushansky Peter · CIK 0002064538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,928 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:05 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 33,846 | $0.00 | $0.00 |
DisclosureSEC source: 0002064538-25-000002 · wk-form4_1762203913.xml · nonDerivative · entry 1 Batushansky Peter · CIK 0002064538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,373 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 20:17 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 2,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-25-000020 · wk-form4_1744402634.xml · nonDerivative · entry 1 Batushansky Peter · CIK 0002064538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,527 F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") Non-Employee Director Equity Compensation Program, which vest on April 9, 2026, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.